⚕ GalenOps CRO console
← 701 (USA)

701-1130

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2014-02-15
Adverse events
8
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild EYE ALLERGY — outcome: RECOVERED/RESOLVED; onset 2014-05-09 (study day 84.0); relationship: NONE

mild assessed 2026-08-18

Mild EYE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-22 (study day 97.0); relationship: REMOTE

mild assessed 2026-08-18

Mild EYE SWELLING — outcome: RECOVERED/RESOLVED; onset 2014-05-09 (study day 84.0); relationship: NONE

mild assessed 2026-08-18

Mild NASAL CONGESTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-22 (study day 97.0); relationship: REMOTE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-22 (study day 97.0); relationship: REMOTE

mild assessed 2026-08-18

Mild PYREXIA — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 23.0); relationship: NONE

mild assessed 2026-08-18

Mild URINARY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-09 (study day 23.0); relationship: NONE

mild assessed 2026-08-18

Mild URINARY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 23.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.